Clinical Trial Update: Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica

View source ↗

Summary

A Costa Rican clinical trial is evaluating the treatment of atopic dermatitis with dupilumab in combination with JAK inhibitors; the study is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)
• JAK inhibitors (unspecified)

Snippet

Sponsor: Caja Costarricense de Seguro Social | Conditions: Atopic Dermatitis, Atopic Dermatitis (AD) | Status: NOT_YET_RECRUITING